Celularity Inc. GXGX

Set alert

10.20 0.00 0.00%

At close

8.07 Day range 12.58

52-week range unavailable

Open: 8.18
Prev close: 10.20
Mkt cap: 201.63M
Vol: 17.32M
Avg vol: 0
EPS: 0.00
P/E: 0.00
Div yield: 0.00%

More statistics

Low: 8.07
High: 12.58
Forward P/E: 0.00
Beta: 0.00
Short ratio: 6.98
Inst. own: 0.00%
Dividend: 0.00
Ex-div date
50-d avg: 10.06
200-d avg: 10.14
1y target: 0.00

Chart tools

Interval

1m 5m 15m 30m

Chart is warming up

The two-year price history for GXGX has not been loaded yet. Try again in a moment.

Market cap: 201.63M
Enterprise value: 0
Trailing P/E: 0.00
Forward P/E: 0.00
PEG ratio: 0.00
Price / sales: 0.00
Price / book: 0.00
EPS (TTM): -0.49
Beta: 0.00
Dividend yield: 0.00%
Payout ratio: 0.00%
Profit margin: 0.00%
Revenue (TTM): 0
Revenue growth: 0.00%
Free cash flow: 0
Total cash: 0
Total debt: 0
Return on equity: 0.00%
Shares outstanding: 12.58M
Short % of float: 6.04%
50-day average: 10.06
200-day average: 10.14

Price target (mean) 0.00

Consensus EPS estimate -0.16.

Earnings history

GXGX analyst upgrades and downgrades
Date	Firm	Action	From	To
Mar 26, 2021	BTIG	init	—	Buy

Celularity Inc., a biopharmaceutical company, develops placental-derived off-the-shelf therapeutic and cellular medicines for cancer, infectious diseases, and degenerative diseases. The company offers Biovance, a human amniotic membrane allograft that provides a protective cover and supports the body's wound healing processes; and Interfyl, a connective tissue matrix for various surgical applications when there is a need to replace and supplement damaged or inadequate integumental tissue. It also offers allogeneic placenta-derived cell therapy product candidates. The company was incorporated in 2016 and is based in Florham Park, New Jersey.

Sector: Financial Services
Industry: Shell Companies
Country: United States
Website: celularity.com

Celularity Inc. GXGX

Key statistics

Analyst view

Next earnings

Upgrades / downgrades

About Celularity Inc.

News

Your note

2Y chart